CBD · CBN · CBG
Cannabinoid education overview
Educational overview of three non-psychoactive cannabinoids: CBD, CBN and CBG. Covers reported effects, evidence quality and interaction context.
Interaction concern
Low concernGeneral educational visualization, not a medical prediction.
Main cautions
Evidence for CBN and CBG remains limited — interpret cautiously
Medication interactions possible — relevant for medication users
Educational context only. Not a use guide.
Risk signal is a general educational visualization based on profile risk levels and known interaction concerns. It is not a medical prediction.
How risk signal works →Legal status varies by country, state and local regulation. Cards are educational context only. How legal context works
Explore related profiles
Full educational profiles for the substances in this card.
CBD
Non-intoxicating cannabinoid discussed for calm and sleep support. Medication interaction concerns and significant product quality variation are key considerations.
Main caution
Significant drug interaction potential — CBD affects liver enzymes that metabolise many medications
Legal: Legal context varies
CBN
Minor cannabinoid associated with sedation-related reports and limited clinical evidence, primarily found in aged cannabis.
Main caution
Clinical evidence for specific effects is limited
Legal: Legal context varies
CBG
Non-intoxicating minor cannabinoid considered a precursor to other cannabinoids, with emerging but limited clinical evidence.
Main caution
Clinical evidence is emerging and limited
Legal: Legal context varies
Educational information only. Not medical advice. Risk signal is a general educational visualization — not a medical prediction. Cards are not use guides or recommendations.